id	sid	eid	entity	type
ajlm-846	1	1	brian r. kullin	PERSON
ajlm-846	1	2	university of cape town	ORG
ajlm-846	1	3	cape town	GPE
ajlm-846	1	4	south africa	GPE
ajlm-846	1	5	sharon reid department	PERSON
ajlm-846	1	6	university of cape town	ORG
ajlm-846	1	7	cape town	GPE
ajlm-846	1	8	south africa valerie abratt	GPE
ajlm-846	1	9	university of cape town	ORG
ajlm-846	1	10	cape town	GPE
ajlm-846	1	11	south africa	GPE
ajlm-846	1	12	kullin br	GPE
ajlm-846	1	13	reid s	PERSON
ajlm-846	1	14	abratt v. clostridium difficile	PERSON
ajlm-846	1	15	cape town	GPE
ajlm-846	1	16	south africa	GPE
ajlm-846	1	17	2014–2015	CARDINAL
ajlm-846	2	1	afr j	PERSON
ajlm-846	2	2	a846	NORP
ajlm-846	3	1	cape town	GPE
ajlm-846	3	2	south africa	GPE
ajlm-846	3	3	2014–2015	CARDINAL
ajlm-846	3	4	brian r. kullin	PERSON
ajlm-846	3	5	sharon reid	PERSON
ajlm-846	3	6	valerie abratt	PERSON
ajlm-846	3	7	04 june 2018	DATE
ajlm-846	3	8	28	CARDINAL
ajlm-846	3	9	sept. 2018	DATE
ajlm-846	3	10	06	CARDINAL
ajlm-846	3	11	dec.	DATE
ajlm-846	4	1	2018	DATE
ajlm-846	4	2	2018	DATE
ajlm-846	8	1	cdi	ORG
ajlm-846	9	1	africa	LOC
ajlm-846	10	1	cdi	ORG
ajlm-846	10	2	south african	NORP
ajlm-846	11	1	cdi	ORG
ajlm-846	11	2	two	CARDINAL
ajlm-846	11	3	xpert®	PERSON
ajlm-846	11	4	c. difficile	PERSON
ajlm-846	13	1	cdi	ORG
ajlm-846	13	2	approximately 70.07	CARDINAL
ajlm-846	13	3	1000	CARDINAL
ajlm-846	14	1	017	CARDINAL
ajlm-846	14	2	over 95%	PERCENT
ajlm-846	16	1	cdi	ORG
ajlm-846	17	1	africa	LOC
ajlm-846	18	1	cdi	ORG
ajlm-846	18	2	cdi	ORG
ajlm-846	18	3	as high as $2871.00	MONEY
ajlm-846	18	4	united states dollars	ORG
ajlm-846	18	5	4846.00	MONEY
ajlm-846	18	6	the united states	GPE
ajlm-846	18	7	between $5243.00 and $8570.00	MONEY
ajlm-846	18	8	european	NORP
ajlm-846	18	9	increasing.3	GPE
ajlm-846	18	10	the turn of the century	DATE
ajlm-846	18	11	cdi	ORG
ajlm-846	18	12	north america	LOC
ajlm-846	18	13	two	CARDINAL
ajlm-846	18	14	third	ORDINAL
ajlm-846	18	15	027	CARDINAL
ajlm-846	18	16	rt078	LOC
ajlm-846	19	1	only one	CARDINAL
ajlm-846	20	1	asia9	PERSON
ajlm-846	20	2	cdi	ORG
ajlm-846	21	1	age,11	ORG
ajlm-846	21	2	therapy12	PERSON
ajlm-846	21	3	debated13	ORG
ajlm-846	21	4	cdi	ORG
ajlm-846	22	1	cdi	ORG
ajlm-846	23	1	chang et al.20	PERSON
ajlm-846	23	2	cdi	ORG
ajlm-846	23	3	hong kong	GPE
ajlm-846	23	4	cdi	ORG
ajlm-846	23	5	lee et al.21	PERSON
ajlm-846	23	6	cdi	ORG
ajlm-846	23	7	korean	NORP
ajlm-846	23	8	2.83	CARDINAL
ajlm-846	23	9	1000	CARDINAL
ajlm-846	24	1	cdi	ORG
ajlm-846	24	2	cape	GPE
ajlm-846	24	3	south africa	GPE
ajlm-846	24	4	at least one	CARDINAL
ajlm-846	24	5	eastern cape	LOC
ajlm-846	25	1	cdi	ORG
ajlm-846	25	2	africa	LOC
ajlm-846	25	3	cdi	ORG
ajlm-846	25	4	europe	LOC
ajlm-846	25	5	south africa	GPE
ajlm-846	25	6	limpopo province	GPE
ajlm-846	25	7	cape	GPE
ajlm-846	25	8	between 10% and 20%	PERCENT
ajlm-846	25	9	diarrhoea.26,27,28	NORP
ajlm-846	25	10	at least two	CARDINAL
ajlm-846	25	11	cdi	ORG
ajlm-846	25	12	cdi	ORG
ajlm-846	25	13	cdi	ORG
ajlm-846	26	1	cdi	ORG
ajlm-846	26	2	two	CARDINAL
ajlm-846	26	3	cape	GPE
ajlm-846	28	1	the ethics committee of the university of cape	ORG
ajlm-846	30	1	two	CARDINAL
ajlm-846	30	2	cape	GPE
ajlm-846	30	3	between september 2014	DATE
ajlm-846	30	4	september 2015	DATE
ajlm-846	30	5	cdi	ORG
ajlm-846	30	6	elsewhere.30	ORG
ajlm-846	30	7	xdr	ORG
ajlm-846	31	1	cdi	ORG
ajlm-846	32	1	the national health laboratory service diagnostic	ORG
ajlm-846	32	2	groote schuur hospital	ORG
ajlm-846	32	3	xpert	PERSON
ajlm-846	32	4	c. difficile	PERSON
ajlm-846	32	5	cepheid	ORG
ajlm-846	32	6	sunnyvale	GPE
ajlm-846	32	7	california	GPE
ajlm-846	32	8	united states	GPE
ajlm-846	34	1	60 °	QUANTITY
ajlm-846	34	2	10 minutes	TIME
ajlm-846	35	1	24–48 hours	TIME
ajlm-846	35	2	37 °	QUANTITY
ajlm-846	35	3	5%	PERCENT
ajlm-846	35	4	10%	PERCENT
ajlm-846	35	5	85%	PERCENT
ajlm-846	35	6	1024	DATE
ajlm-846	35	7	marietta	GPE
ajlm-846	35	8	ohio	GPE
ajlm-846	35	9	united states	GPE
ajlm-846	36	1	cdta	PERSON
ajlm-846	36	2	ribotyping34	ORG
ajlm-846	36	3	the swedish institute for	ORG
ajlm-846	36	4	described.35	PERSON
ajlm-846	36	5	manhattan	GPE
ajlm-846	37	1	kruskal	PERSON
ajlm-846	37	2	2.4)36	CARDINAL
ajlm-846	37	3	2000	CARDINAL
ajlm-846	38	1	two	CARDINAL
ajlm-846	39	1	biomérieux	GPE
ajlm-846	39	2	johannesburg	GPE
ajlm-846	39	3	south africa	GPE
ajlm-846	39	4	degli abruzzi	PERSON
ajlm-846	39	5	italy	GPE
ajlm-846	39	6	5%	PERCENT
ajlm-846	39	7	5 μg/ml	QUANTITY
ajlm-846	39	8	10 μg/ml	QUANTITY
ajlm-846	40	1	european committee	ORG
ajlm-846	40	2	tables41	ORG
ajlm-846	40	3	700057	DATE
ajlm-846	40	4	11/11	CARDINAL
ajlm-846	40	5	xpert	PERSON
ajlm-846	40	6	september 2014	DATE
ajlm-846	40	7	september 2015	DATE
ajlm-846	40	8	212	CARDINAL
ajlm-846	40	9	two	CARDINAL
ajlm-846	41	1	slightly more than half	CARDINAL
ajlm-846	41	2	120	CARDINAL
ajlm-846	41	3	56.6%	PERCENT
ajlm-846	42	1	seven	CARDINAL
ajlm-846	43	1	two	CARDINAL
ajlm-846	43	2	two-week	DATE
ajlm-846	43	3	five	CARDINAL
ajlm-846	44	1	60	CARDINAL
ajlm-846	44	2	161	CARDINAL
ajlm-846	44	3	90 days	DATE
ajlm-846	45	1	nine	CARDINAL
ajlm-846	45	2	two	CARDINAL
ajlm-846	46	1	117	CARDINAL
ajlm-846	46	2	55.7%	PERCENT
ajlm-846	46	3	77	DATE
ajlm-846	46	4	36.7%	PERCENT
ajlm-846	46	5	four	CARDINAL
ajlm-846	46	6	1.9%	PERCENT
ajlm-846	46	7	xdr	ORG
ajlm-846	47	1	12	CARDINAL
ajlm-846	47	2	5.7%	PERCENT
ajlm-846	48	1	xpert c. difficile-	PERSON
ajlm-846	48	2	152	CARDINAL
ajlm-846	48	3	72.4%	PERCENT
ajlm-846	48	4	1	CARDINAL
ajlm-846	49	1	three	CARDINAL
ajlm-846	49	2	1.4%	PERCENT
ajlm-846	50	1	approximately 84.05	CARDINAL
ajlm-846	50	2	1000	CARDINAL
ajlm-846	50	3	approximately 60.03	CARDINAL
ajlm-846	50	4	1000	CARDINAL
ajlm-846	50	5	70.07	CARDINAL
ajlm-846	50	6	1000	CARDINAL
ajlm-846	51	1	145	CARDINAL
ajlm-846	51	2	69%	PERCENT
ajlm-846	51	3	between the ages of 24	DATE
ajlm-846	51	4	45	DATE
ajlm-846	51	5	xpert c. difficile	PERSON
ajlm-846	51	6	31–45.25	CARDINAL
ajlm-846	51	7	xpert c. difficile negative	PERSON
ajlm-846	51	8	30–40	CARDINAL
ajlm-846	52	1	1	CARDINAL
ajlm-846	53	1	xpert	PERSON
ajlm-846	53	2	c. difficile	PERSON
ajlm-846	53	3	xpert	PERSON
ajlm-846	55	1	xpert c. difficile-	PERSON
ajlm-846	55	2	two	CARDINAL
ajlm-846	55	3	28-day	DATE
ajlm-846	55	4	cdi	ORG
ajlm-846	55	5	2	CARDINAL
ajlm-846	56	1	five	CARDINAL
ajlm-846	56	2	28-day	DATE
ajlm-846	57	1	2	CARDINAL
ajlm-846	57	2	four	CARDINAL
ajlm-846	58	1	3	CARDINAL
ajlm-846	58	2	two	CARDINAL
ajlm-846	58	3	first	ORDINAL
ajlm-846	58	4	november	DATE
ajlm-846	58	5	december 2014	DATE
ajlm-846	58	6	second	ORDINAL
ajlm-846	59	1	three	CARDINAL
ajlm-846	59	2	two	CARDINAL
ajlm-846	60	1	1	CARDINAL
ajlm-846	60	2	3	CARDINAL
ajlm-846	60	3	november	DATE
ajlm-846	60	4	december 2014	DATE
ajlm-846	60	5	january 2015	DATE
ajlm-846	60	6	1	CARDINAL
ajlm-846	60	7	2	CARDINAL
ajlm-846	60	8	cdi	ORG
ajlm-846	61	1	cdi	ORG
ajlm-846	61	2	28-day	DATE
ajlm-846	62	1	one-day	DATE
ajlm-846	64	1	152	CARDINAL
ajlm-846	64	2	xpert c. difficile	PERSON
ajlm-846	64	3	only 119	CARDINAL
ajlm-846	64	4	78.3%	PERCENT
ajlm-846	65	1	toxigenic c. difficile	PERSON
ajlm-846	65	2	110	CARDINAL
ajlm-846	65	3	110	CARDINAL
ajlm-846	65	4	92.4%	PERCENT
ajlm-846	66	1	105	CARDINAL
ajlm-846	66	2	95.5%	PERCENT
ajlm-846	67	1	five	CARDINAL
ajlm-846	67	2	one	CARDINAL
ajlm-846	67	3	rt046	PERSON
ajlm-846	67	4	one	CARDINAL
ajlm-846	67	5	rt(se)108	PERSON
ajlm-846	67	6	three	CARDINAL
ajlm-846	67	7	two	CARDINAL
ajlm-846	68	1	just over half	CARDINAL
ajlm-846	68	2	53.4%	PERCENT
ajlm-846	68	3	one	CARDINAL
ajlm-846	68	4	3a	CARDINAL
ajlm-846	69	1	four	CARDINAL
ajlm-846	69	2	cdi	ORG
ajlm-846	70	1	second	ORDINAL
ajlm-846	70	2	eight	CARDINAL
ajlm-846	70	3	three	CARDINAL
ajlm-846	70	4	four	CARDINAL
ajlm-846	70	5	between january 2015 and	DATE
ajlm-846	70	6	november 2015	DATE
ajlm-846	71	1	three	CARDINAL
ajlm-846	71	2	3b	CARDINAL
ajlm-846	71	3	76.9%	PERCENT
ajlm-846	73	1	three or	CARDINAL
ajlm-846	73	2	four	CARDINAL
ajlm-846	74	1	3	CARDINAL
ajlm-846	80	1	3	CARDINAL
ajlm-846	86	1	77	CARDINAL
ajlm-846	86	2	43	CARDINAL
ajlm-846	86	3	34	CARDINAL
ajlm-846	87	1	1	CARDINAL
ajlm-846	88	1	four	CARDINAL
ajlm-846	88	2	2 mg/l	QUANTITY
ajlm-846	89	1	one	CARDINAL
ajlm-846	91	1	over two-thirds	CARDINAL
ajlm-846	91	2	72.6%	PERCENT
ajlm-846	92	1	2	CARDINAL
ajlm-846	92	2	73.6%	PERCENT
ajlm-846	92	3	26.4%	PERCENT
ajlm-846	93	1	two	CARDINAL
ajlm-846	95	1	1	CARDINAL
ajlm-846	96	1	2	CARDINAL
ajlm-846	97	1	cdi	ORG
ajlm-846	97	2	africa	LOC
ajlm-846	98	1	cdi	ORG
ajlm-846	98	2	cdi	ORG
ajlm-846	99	1	one	CARDINAL
ajlm-846	100	1	first	ORDINAL
ajlm-846	100	2	cdi	ORG
ajlm-846	100	3	cdi	ORG
ajlm-846	101	1	africa	LOC
ajlm-846	102	1	cdi	ORG
ajlm-846	103	1	cdi	ORG
ajlm-846	103	2	at least four	CARDINAL
ajlm-846	104	1	three	CARDINAL
ajlm-846	104	2	one	CARDINAL
ajlm-846	105	1	five	CARDINAL
ajlm-846	105	2	at least 20	CARDINAL
ajlm-846	105	3	four-week	DATE
ajlm-846	106	1	four	CARDINAL
ajlm-846	108	1	china,46 korea,47	ORG
ajlm-846	108	2	30-day	DATE
ajlm-846	109	1	cape	GPE
ajlm-846	111	1	england	GPE
ajlm-846	112	1	two	CARDINAL
ajlm-846	112	2	1–28 days	DATE
ajlm-846	112	3	cdi	ORG
ajlm-846	113	1	three	CARDINAL
ajlm-846	114	1	28-day	DATE
ajlm-846	115	1	three to seven months	DATE
ajlm-846	117	1	cdi	ORG
ajlm-846	119	1	4 mg	QUANTITY
ajlm-846	119	2	between 0.25 mg/l and 9.5 mg	QUANTITY
ajlm-846	119	3	cdi	ORG
ajlm-846	119	4	south africa	GPE
ajlm-846	120	1	one	CARDINAL
ajlm-846	121	1	37%	PERCENT
ajlm-846	121	2	europe	LOC
ajlm-846	121	3	0%	PERCENT
ajlm-846	121	4	63.64%).42	CARDINAL
ajlm-846	122	1	cdi	ORG
ajlm-846	122	2	third	ORDINAL
ajlm-846	122	3	fourth	ORDINAL
ajlm-846	122	4	north america	LOC
ajlm-846	122	5	the early	DATE
ajlm-846	122	6	south africa	GPE
ajlm-846	126	1	one	CARDINAL
ajlm-846	126	2	cdi	ORG
ajlm-846	126	3	cdi	ORG
ajlm-846	127	1	fourth	ORDINAL
ajlm-846	128	1	cdi	ORG
ajlm-846	128	2	town22	PERSON
ajlm-846	128	3	hong kong20	GPE
ajlm-846	131	1	scheme,30,35	ORG
ajlm-846	133	1	cape	GPE
ajlm-846	135	1	cdi	ORG
ajlm-846	136	1	cdi	ORG
ajlm-846	137	1	cdi	ORG
ajlm-846	139	1	the national health laboratory service	ORG
ajlm-846	140	1	dr justyna wojno	PERSON
ajlm-846	140	2	dr lourens	PERSON
ajlm-846	140	3	dr diane rip	PERSON
ajlm-846	140	4	zubeida salaam-dreyer	GPE
ajlm-846	140	5	national health laboratory service	ORG
ajlm-846	142	1	the national research foundation of south africa	ORG
ajlm-846	143	1	claude leon foundation	ORG
ajlm-846	143	2	the carnegie corporation	ORG
ajlm-846	143	3	new york	GPE
ajlm-846	144	1	s.r.	GPE
ajlm-846	144	2	v.a.	GPE
ajlm-846	147	1	s.r.	GPE
ajlm-846	147	2	v.a.	GPE
ajlm-846	148	1	s.r.	GPE
ajlm-846	148	2	v.a.	GPE
ajlm-846	149	1	freeman j	PERSON
ajlm-846	149	2	bauer mp	PERSON
ajlm-846	149	3	baines	PERSON
ajlm-846	151	1	clin	PERSON
ajlm-846	151	2	2010;23:529–549	CARDINAL
ajlm-846	152	1	ghantoji ss	PERSON
ajlm-846	152	2	sail k	PERSON
ajlm-846	152	3	lairson dr	PERSON
ajlm-846	155	1	2010;74:309–318	CARDINAL
ajlm-846	156	1	vardakas kz	ORG
ajlm-846	156	2	polyzos ka	PERSON
ajlm-846	157	1	j antimicrob	PERSON
ajlm-846	158	1	2012;40:1–8	CARDINAL
ajlm-846	159	1	shutt k	PERSON
ajlm-846	162	1	2005;26:273–280	CARDINAL
ajlm-846	163	1	dutilh jc	PERSON
ajlm-846	163	2	2	CARDINAL
ajlm-846	163	3	1	CARDINAL
ajlm-846	164	1	clin infect dis	ORG
ajlm-846	166	1	https://doi.org/10.1093/cid/cir549 cairns md	PERSON
ajlm-846	166	2	preston md	GPE
ajlm-846	166	3	lawley	GPE
ajlm-846	167	1	017	CARDINAL
ajlm-846	167	2	london	GPE
ajlm-846	167	3	england	GPE
ajlm-846	168	1	j clin microbiol	PERSON
ajlm-846	169	1	2015;53:3141–3147	CARDINAL
ajlm-846	170	1	kuehne sa	PERSON
ajlm-846	170	2	cartman st	PERSON
ajlm-846	170	3	minton np	PERSON
ajlm-846	173	1	2011;2:252–255	CARDINAL
ajlm-846	174	1	stewart db	PERSON
ajlm-846	174	2	berg	PERSON
ajlm-846	175	1	j gastrointest surg	PERSON
ajlm-846	176	1	2013;17:118–124	CARDINAL
ajlm-846	177	1	124–125	CARDINAL
ajlm-846	178	1	collins da	PERSON
ajlm-846	178	2	riley tv	PERSON
ajlm-846	179	1	asia	LOC
ajlm-846	180	1	antimicrob	PERSON
ajlm-846	181	1	2013;2:21	CARDINAL
ajlm-846	184	1	j antimicrob	PERSON
ajlm-846	186	1	https://doi.org/10.1093/jac/dkt477 vardakas kz	ORG
ajlm-846	186	2	konstantelias aa	PERSON
ajlm-846	189	1	2012;16	CARDINAL
ajlm-846	190	1	oshima t	PERSON
ajlm-846	190	2	wu l	PERSON
ajlm-846	190	3	li m	PERSON
ajlm-846	191	1	j gastroenterol	PERSON
ajlm-846	193	1	kogan s	PERSON
ajlm-846	194	1	plos	PERSON
ajlm-846	194	2	one	CARDINAL
ajlm-846	195	1	2014;9	CARDINAL
ajlm-846	196	1	https://doi.org/10.1371/journal.pone.0110790 haines	PERSON
ajlm-846	196	2	moore rd	PERSON
ajlm-846	196	3	bartlett jg	PERSON
ajlm-846	198	1	2013;27:2799–2807	CARDINAL
ajlm-846	198	2	ziakas pd	GPE
ajlm-846	200	1	plos one	PERSON
ajlm-846	201	1	2015;10	CARDINAL
ajlm-846	203	1	046	CARDINAL
ajlm-846	203	2	poland	GPE
ajlm-846	204	1	eur	CARDINAL
ajlm-846	204	2	j clin microbiol	PERSON
ajlm-846	205	1	2013;32:1027–1030	PERSON
ajlm-846	206	1	https://doi.org/10.1007/s10096-013-1845-5 sun y-x	PERSON
ajlm-846	206	2	zhao y-t	PERSON
ajlm-846	206	3	teng l-l	PERSON
ajlm-846	208	1	2013;52:1495–1497	CARDINAL
ajlm-846	209	1	jung s-w	ORG
ajlm-846	209	2	jeon s-w	ORG
ajlm-846	210	1	j clin gastroenterol	PERSON
ajlm-846	211	1	2007;41:38–40	CARDINAL
ajlm-846	212	1	wang p	PERSON
ajlm-846	212	2	zhou y	PERSON
ajlm-846	212	3	wang z	PERSON
ajlm-846	212	4	027	CARDINAL
ajlm-846	212	5	first	ORDINAL
ajlm-846	212	6	china	GPE
ajlm-846	214	1	2014;35:95–98	CARDINAL
ajlm-846	215	1	chang kc	PERSON
ajlm-846	215	2	leung cc	PERSON
ajlm-846	219	1	lee ym	PERSON
ajlm-846	220	1	kc	PERSON
ajlm-846	220	2	yoon sm	PERSON
ajlm-846	222	1	2016;10(2):250–254	CARDINAL
ajlm-846	222	2	legenza l	PERSON
ajlm-846	222	3	barnett s	ORG
ajlm-846	222	4	south africa	GPE
ajlm-846	223	1	bmj	ORG
ajlm-846	225	1	https://doi.org/10.1136/bmjgh-2018-000889 national institute of communicable	ORG
ajlm-846	226	1	eastern cape province	LOC
ajlm-846	227	1	nicd commun dis commun	ORG
ajlm-846	228	1	2016;15:6–7	CARDINAL
ajlm-846	229	1	keeley aj	PERSON
ajlm-846	229	2	nj	ORG
ajlm-846	229	3	stott ke	PERSON
ajlm-846	229	4	africa	LOC
ajlm-846	230	1	malawi	GPE
ajlm-846	230	2	j. 2016;28:66–69	ORG
ajlm-846	231	1	roldan ga	PERSON
ajlm-846	233	1	j clin microbiol	PERSON
ajlm-846	234	1	2018;56(3):e01747–17	CARDINAL
ajlm-846	235	1	kullin	GPE
ajlm-846	235	2	d’alton j	GPE
ajlm-846	236	1	schuur hospital	ORG
ajlm-846	236	2	cape town	GPE
ajlm-846	236	3	south africa	GPE
ajlm-846	237	1	south afr med j. 2015;105:121–125	FAC
ajlm-846	238	1	pentecost m	ORG
ajlm-846	239	1	south african	NORP
ajlm-846	239	2	tertiary	ORDINAL
ajlm-846	240	1	j. 2013;103:168–172	PRODUCT
ajlm-846	242	1	cdta	PERSON
ajlm-846	242	2	south africa	GPE
ajlm-846	243	1	j trop med	PERSON
ajlm-846	245	1	https://doi.org/10.4269/ajtmh.2008.78.577	NORP
ajlm-846	245	2	lewis e	PERSON
ajlm-846	245	3	hoosen	PERSON
ajlm-846	249	1	https://doi.org/10.1016/j.jhin.2010.03.016 kullin	PERSON
ajlm-846	251	1	017	CARDINAL
ajlm-846	251	2	cape town	GPE
ajlm-846	251	3	south africa	GPE
ajlm-846	252	1	eur	CARDINAL
ajlm-846	252	2	j clin microbiol	PERSON
ajlm-846	253	1	2017;36:163–175	CARDINAL
ajlm-846	256	1	clin infect dis	ORG
ajlm-846	257	1	1993;16	CARDINAL
ajlm-846	258	1	stubbs s	PERSON
ajlm-846	259	1	adp	ORG
ajlm-846	261	1	2000;186:307–312	CARDINAL
ajlm-846	262	1	https://doi.org/10.1111/j.1574-6968.2000.tb09122.x lemee l	ORG
ajlm-846	263	1	multiplex	NORP
ajlm-846	264	1	j clin microbiol	PERSON
ajlm-846	265	1	2004;42:5710–5714	PERSON
ajlm-846	266	1	knetsch cw	ORG
ajlm-846	266	2	maccannell dr	PERSON
ajlm-846	267	1	plos one	PERSON
ajlm-846	268	1	2015;10	CARDINAL
ajlm-846	270	1	https://doi.org/10.1371/journal.pone.0118150 van den berg rj	PERSON
ajlm-846	270	2	schaap	PERSON
ajlm-846	270	3	templeton ke	PERSON
ajlm-846	272	1	j clin microbiol	PERSON
ajlm-846	273	1	2007;45:1024–1028	LANGUAGE
ajlm-846	274	1	hall bg	PERSON
ajlm-846	276	1	j clin microbiol	PERSON
ajlm-846	277	1	2011;49:3568–3575	ORG
ajlm-846	278	1	bastian m	PERSON
ajlm-846	278	2	heymann s	PERSON
ajlm-846	278	3	jacomy m. gephi	PERSON
ajlm-846	280	1	2009	DATE
ajlm-846	281	1	2018	DATE
ajlm-846	282	1	eyre dw	PERSON
ajlm-846	282	2	fawley	GPE
ajlm-846	283	1	j clin microbiol	PERSON
ajlm-846	284	1	2013;51:4141–4149	CARDINAL
ajlm-846	285	1	marsh jw	PERSON
ajlm-846	285	2	shutt ka	PERSON
ajlm-846	287	1	j clin microbiol	PERSON
ajlm-846	288	1	2006;44:2558–2566	CARDINAL
ajlm-846	289	1	https://doi.org/10.1128/jcm.02364-05	ORG
ajlm-846	291	1	28th	ORDINAL
ajlm-846	291	2	clsi	PERSON
ajlm-846	291	3	m100	PRODUCT
ajlm-846	293	1	wayne	PERSON
ajlm-846	293	2	pa, usa: clinical and laboratory standards institute	ORG
ajlm-846	293	3	2018	DATE
ajlm-846	295	1	the european committee	ORG
ajlm-846	298	1	8.1	CARDINAL
ajlm-846	299	1	2018	DATE
ajlm-846	300	1	2018	DATE
ajlm-846	301	1	http://www.eucast.org freeman j	PERSON
ajlm-846	301	2	vernon j	PERSON
ajlm-846	301	3	morris k	PERSON
ajlm-846	302	1	pan-european	NORP
ajlm-846	303	1	clin	PERSON
ajlm-846	305	1	freeman j	PERSON
ajlm-846	306	1	j antimicrob	PERSON
ajlm-846	308	1	https://doi.org/10.1093/jac/dkn313 wilcox mh	ORG
ajlm-846	308	2	fawley	GPE
ajlm-846	308	3	england	GPE
ajlm-846	309	1	clin infect dis	ORG
ajlm-846	310	1	2012;55:1056–1063	CARDINAL
ajlm-846	311	1	al-barrak	PERSON
ajlm-846	312	1	canadian	NORP
ajlm-846	313	1	commun	PERSON
ajlm-846	314	1	marriott	GPE
ajlm-846	314	2	liu	PERSON
ajlm-846	315	1	chinese	NORP
ajlm-846	315	2	asia	LOC
ajlm-846	316	1	j clin microbiol	PERSON
ajlm-846	317	1	2013;51:3308–3313	CARDINAL
ajlm-846	318	1	kim	PERSON
ajlm-846	318	2	riley tv	ORG
ajlm-846	318	3	kim m	PERSON
ajlm-846	319	1	korea	GPE
ajlm-846	320	1	j clin microbiol	PERSON
ajlm-846	321	1	2008;46:1116–1117	CARDINAL
ajlm-846	322	1	legaria mc	PERSON
ajlm-846	322	2	van den berg rj	PERSON
ajlm-846	322	3	buenos aires	GPE
ajlm-846	322	4	argentina	GPE
ajlm-846	323	1	clin microbiol	ORG
ajlm-846	324	1	2009;15:1080–1086	CARDINAL
ajlm-846	325	1	bahar j.	PERSON
ajlm-846	327	1	https://doi.org/10.1016/s0732-8893(02)00400-5 komatsu m	ORG
ajlm-846	327	2	kato h	ORG
ajlm-846	327	3	aihara m	PERSON
ajlm-846	327	4	japan	GPE
ajlm-846	328	1	j clin microbiol	PERSON
ajlm-846	330	1	dublin	GPE
ajlm-846	330	2	ireland	GPE
ajlm-846	331	1	clin microbiol	ORG
ajlm-846	333	1	spigaglia p	PERSON
ajlm-846	333	2	mastrantonio p	PERSON
ajlm-846	334	1	european	NORP
ajlm-846	335	1	j antimicrob	PERSON
ajlm-846	336	1	2011;66:2227–2234.	CARDINAL
ajlm-846	337	1	eyre dw	PERSON
ajlm-846	338	1	clin infect dis	ORG
ajlm-846	339	1	2013;56:1589–1600	CARDINAL
ajlm-846	340	1	https://doi.org/10.1093/cid/cit127 kullin	PERSON
ajlm-846	340	2	brock t, rajabally	GPE
ajlm-846	340	3	schuur hospital	ORG
ajlm-846	340	4	cape town	GPE
ajlm-846	340	5	south africa	GPE
ajlm-846	341	1	eur	CARDINAL
ajlm-846	341	2	j clin microbiol	PERSON
ajlm-846	342	1	2016;35:1709–1718	PERSON
ajlm-846	343	1	https://doi.org/10.1007/s10096-016-2717-6 eyre dw	PERSON
ajlm-846	343	2	cule ml	PERSON
ajlm-846	343	3	wilson	PERSON
ajlm-846	346	1	2013;369:1195–1205	CARDINAL
ajlm-846	347	1	marsh jw	GPE
ajlm-846	347	2	shutt ka	PERSON
ajlm-846	348	1	clin infect dis	ORG
ajlm-846	349	1	2009;48:425–429	CARDINAL
ajlm-846	350	1	dang ut	GPE
ajlm-846	350	2	zamora	ORG
ajlm-846	353	1	antimicrob	PERSON
ajlm-846	354	1	2016;60:5604–5607	CARDINAL
ajlm-846	355	1	dawson l	GPE
ajlm-846	355	2	027	CARDINAL
ajlm-846	357	1	2009;10	CARDINAL
ajlm-846	357	2	gyra	GPE
ajlm-846	358	1	antimicrob	PERSON
ajlm-846	360	1	louie t	PERSON
ajlm-846	362	1	antimicrob	PERSON
ajlm-846	363	1	2009;53:2463–2468	PERSON
ajlm-846	364	1	kuehne sa	PERSON
ajlm-846	364	2	cartman st	PERSON
ajlm-846	365	1	antimicrob	PERSON
ajlm-846	366	1	2015;59:1794–1796	CARDINAL